Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2017-2020

ABSTRACT

The Zika infection is a viral disease that is transmitted to humans by the same mosquito that transmits Dengue and Chikungunya fever. The Zika virus has been found in various body fluids such as urine, blood and semen, but we do not know how long it persists in these fluids. For example, parts of the virus were reported to persist in semen after six months of the onset of symptoms, but we do not know if the virus can stay longer. In this way, we want to investigate how long the Zika virus can be found in other secretions besides blood and urine. Study Hypothesis: ZIKV can be shed in human body fluids long after the time of the acute infection. Persistence of ZIKV in different body fluids may vary due to the influence of circulating specific ZIKV IgM and IgG, as well as host and environmental factors. Detailed Description Little is known about Zika virus (ZIKV) biology and its pathogenesis in humans. ZIKV has been detected in blood, urine, semen, cerebral spinal fluid, saliva, amniotic fluid, and breast milk. In most ZIKV infected individuals, the virus is detected in the blood from a several days to one week after the onset of symptoms and has also been found to persist longer in urine and semen. Without a more granular understanding of the kinetics of ZIKV infection across biologic compartments it will be difficult to devise rational measures to prevent the transmission of the virus. This will be an observational cohort study of men and women, aged 18 years and above, including symptomatic participants with positive reverse transcriptase-polymerase chain reaction (RT-PCR) test in blood and/or urine and their symptomatic or asymptomatic household/sexual contacts with positive RT-PCR in blood and/or urine. Specimens to be collected at pre-established intervals and tested for ZIKV RNA by RT-PCR are blood, semen, vaginal secretions, oral fluid (saliva and crevicular fluid), tears, sweat, urine, rectal swab, menstrual blood and breast milk (if applicable). Participants will be recruited from collaborating clinics in selected locations with high population density, high circulation of the virus, strong community network, and serviced by laboratory facilities with capacity to perform the necessary tests. All participants will be followed up for 12 months, to assess detectability at longer time intervals, reactivation or reinfection. Analyses of antibody response, including circulating immunoglobulins M and G (IgM and IgG), will be performed in parallel to RT-PCR tests. Plaque reduction neutralization test will be performed in specimens of participants who are found to be simultaneously positive for ZIKV and dengue. Specific analysis will be performed to determine if socio-demographic characteristics, comorbidities and co-infections influence the persistence of the virus in the body fluids. More... »

URL

https://clinicaltrials.gov/show/NCT03106714

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The Zika infection is a viral disease that is transmitted to humans by the same mosquito that transmits Dengue and Chikungunya fever. The Zika virus has been found in various body fluids such as urine, blood and semen, but we do not know how long it persists in these fluids. For example, parts of the virus were reported to persist in semen after six months of the onset of symptoms, but we do not know if the virus can stay longer. In this way, we want to investigate how long the Zika virus can be found in other secretions besides blood and urine. Study Hypothesis: ZIKV can be shed in human body fluids long after the time of the acute infection. Persistence of ZIKV in different body fluids may vary due to the influence of circulating specific ZIKV IgM and IgG, as well as host and environmental factors.\n\nDetailed Description\nLittle is known about Zika virus (ZIKV) biology and its pathogenesis in humans. ZIKV has been detected in blood, urine, semen, cerebral spinal fluid, saliva, amniotic fluid, and breast milk. In most ZIKV infected individuals, the virus is detected in the blood from a several days to one week after the onset of symptoms and has also been found to persist longer in urine and semen. Without a more granular understanding of the kinetics of ZIKV infection across biologic compartments it will be difficult to devise rational measures to prevent the transmission of the virus. This will be an observational cohort study of men and women, aged 18 years and above, including symptomatic participants with positive reverse transcriptase-polymerase chain reaction (RT-PCR) test in blood and/or urine and their symptomatic or asymptomatic household/sexual contacts with positive RT-PCR in blood and/or urine. Specimens to be collected at pre-established intervals and tested for ZIKV RNA by RT-PCR are blood, semen, vaginal secretions, oral fluid (saliva and crevicular fluid), tears, sweat, urine, rectal swab, menstrual blood and breast milk (if applicable). Participants will be recruited from collaborating clinics in selected locations with high population density, high circulation of the virus, strong community network, and serviced by laboratory facilities with capacity to perform the necessary tests. All participants will be followed up for 12 months, to assess detectability at longer time intervals, reactivation or reinfection. Analyses of antibody response, including circulating immunoglobulins M and G (IgM and IgG), will be performed in parallel to RT-PCR tests. Plaque reduction neutralization test will be performed in specimens of participants who are found to be simultaneously positive for ZIKV and dengue. Specific analysis will be performed to determine if socio-demographic characteristics, comorbidities and co-infections influence the persistence of the virus in the body fluids.", 
    "endDate": "2020-02-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03106714", 
    "keywords": [
      "virus", 
      "body fluid", 
      "virus infection", 
      "infection", 
      "Virus Disease", 
      "human", 
      "chikungunya", 
      "fever", 
      "urine", 
      "blood", 
      "semen", 
      "fluid", 
      "onset", 
      "symptom", 
      "Bodily Secretion", 
      "study hypothesis", 
      "human body fluid", 
      "acute infection", 
      "persistence", 
      "IgM and IgG", 
      "host", 
      "environmental factor", 
      "Little", 
      "biology", 
      "pathogenesis", 
      "cerebral spinal fluid", 
      "saliva", 
      "amniotic fluid", 
      "Human Milk", 
      "infected individual", 
      "kinetics", 
      "compartment", 
      "transmission", 
      "observational cohort study", 
      "men", 
      "woman", 
      "reverse transcriptase-polymerase chain reaction", 
      "RT-PCR", 
      "specimen", 
      "interval", 
      "vaginal secretion", 
      "oral fluid", 
      "tear", 
      "sweat", 
      "swab", 
      "collaborating", 
      "selected location", 
      "high population density", 
      "circulation", 
      "community network", 
      "laboratory facility", 
      "capacity", 
      "detectability", 
      "long time interval", 
      "reactivation", 
      "reinfection", 
      "Antibody Formation", 
      "immunoglobulin", 
      "parallel", 
      "neutralization", 
      "dengue", 
      "specific analysis", 
      "socio-demographic characteristic", 
      "comorbidity", 
      "Coinfection"
    ], 
    "name": "Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03106714"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00024.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.94365.3d", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.3575.4", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.418153.a", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.418068.3", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.52788.30", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.414596.b", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.420210.5", 
        "type": "Organization"
      }
    ], 
    "startDate": "2017-07-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/s12879-018-2965-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100561282", 
          "https://doi.org/10.1186/s12879-018-2965-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12879-018-2965-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100561282", 
          "https://doi.org/10.1186/s12879-018-2965-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03106714"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03106714'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03106714'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03106714'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03106714'


 

This table displays all metadata directly associated to this object as RDF triples.

100 TRIPLES      16 PREDICATES      87 URIs      74 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03106714 schema:about anzsrc-for:3114
2 schema:description The Zika infection is a viral disease that is transmitted to humans by the same mosquito that transmits Dengue and Chikungunya fever. The Zika virus has been found in various body fluids such as urine, blood and semen, but we do not know how long it persists in these fluids. For example, parts of the virus were reported to persist in semen after six months of the onset of symptoms, but we do not know if the virus can stay longer. In this way, we want to investigate how long the Zika virus can be found in other secretions besides blood and urine. Study Hypothesis: ZIKV can be shed in human body fluids long after the time of the acute infection. Persistence of ZIKV in different body fluids may vary due to the influence of circulating specific ZIKV IgM and IgG, as well as host and environmental factors. Detailed Description Little is known about Zika virus (ZIKV) biology and its pathogenesis in humans. ZIKV has been detected in blood, urine, semen, cerebral spinal fluid, saliva, amniotic fluid, and breast milk. In most ZIKV infected individuals, the virus is detected in the blood from a several days to one week after the onset of symptoms and has also been found to persist longer in urine and semen. Without a more granular understanding of the kinetics of ZIKV infection across biologic compartments it will be difficult to devise rational measures to prevent the transmission of the virus. This will be an observational cohort study of men and women, aged 18 years and above, including symptomatic participants with positive reverse transcriptase-polymerase chain reaction (RT-PCR) test in blood and/or urine and their symptomatic or asymptomatic household/sexual contacts with positive RT-PCR in blood and/or urine. Specimens to be collected at pre-established intervals and tested for ZIKV RNA by RT-PCR are blood, semen, vaginal secretions, oral fluid (saliva and crevicular fluid), tears, sweat, urine, rectal swab, menstrual blood and breast milk (if applicable). Participants will be recruited from collaborating clinics in selected locations with high population density, high circulation of the virus, strong community network, and serviced by laboratory facilities with capacity to perform the necessary tests. All participants will be followed up for 12 months, to assess detectability at longer time intervals, reactivation or reinfection. Analyses of antibody response, including circulating immunoglobulins M and G (IgM and IgG), will be performed in parallel to RT-PCR tests. Plaque reduction neutralization test will be performed in specimens of participants who are found to be simultaneously positive for ZIKV and dengue. Specific analysis will be performed to determine if socio-demographic characteristics, comorbidities and co-infections influence the persistence of the virus in the body fluids.
3 schema:endDate 2020-02-01T00:00:00Z
4 schema:keywords Antibody Formation
5 Bodily Secretion
6 Coinfection
7 Human Milk
8 IgM and IgG
9 Little
10 RT-PCR
11 Virus Disease
12 acute infection
13 amniotic fluid
14 biology
15 blood
16 body fluid
17 capacity
18 cerebral spinal fluid
19 chikungunya
20 circulation
21 collaborating
22 community network
23 comorbidity
24 compartment
25 dengue
26 detectability
27 environmental factor
28 fever
29 fluid
30 high population density
31 host
32 human
33 human body fluid
34 immunoglobulin
35 infected individual
36 infection
37 interval
38 kinetics
39 laboratory facility
40 long time interval
41 men
42 neutralization
43 observational cohort study
44 onset
45 oral fluid
46 parallel
47 pathogenesis
48 persistence
49 reactivation
50 reinfection
51 reverse transcriptase-polymerase chain reaction
52 saliva
53 selected location
54 semen
55 socio-demographic characteristic
56 specific analysis
57 specimen
58 study hypothesis
59 swab
60 sweat
61 symptom
62 tear
63 transmission
64 urine
65 vaginal secretion
66 virus
67 virus infection
68 woman
69 schema:name Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
70 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03106714
71 schema:sdDatePublished 2019-03-07T15:27
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N872ffdf19c70433893c13aec3e558768
74 schema:sponsor https://www.grid.ac/institutes/grid.3575.4
75 https://www.grid.ac/institutes/grid.414596.b
76 https://www.grid.ac/institutes/grid.418068.3
77 https://www.grid.ac/institutes/grid.418153.a
78 https://www.grid.ac/institutes/grid.420210.5
79 https://www.grid.ac/institutes/grid.52788.30
80 https://www.grid.ac/institutes/grid.94365.3d
81 schema:startDate 2017-07-01T00:00:00Z
82 schema:subjectOf sg:pub.10.1186/s12879-018-2965-4
83 schema:url https://clinicaltrials.gov/show/NCT03106714
84 sgo:license sg:explorer/license/
85 sgo:sdDataset clinical_trials
86 rdf:type schema:MedicalStudy
87 N872ffdf19c70433893c13aec3e558768 schema:name Springer Nature - SN SciGraph project
88 rdf:type schema:Organization
89 anzsrc-for:3114 schema:inDefinedTermSet anzsrc-for:
90 rdf:type schema:DefinedTerm
91 sg:pub.10.1186/s12879-018-2965-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100561282
92 https://doi.org/10.1186/s12879-018-2965-4
93 rdf:type schema:CreativeWork
94 https://www.grid.ac/institutes/grid.3575.4 schema:Organization
95 https://www.grid.ac/institutes/grid.414596.b schema:Organization
96 https://www.grid.ac/institutes/grid.418068.3 schema:Organization
97 https://www.grid.ac/institutes/grid.418153.a schema:Organization
98 https://www.grid.ac/institutes/grid.420210.5 schema:Organization
99 https://www.grid.ac/institutes/grid.52788.30 schema:Organization
100 https://www.grid.ac/institutes/grid.94365.3d schema:Organization
 




Preview window. Press ESC to close (or click here)


...